BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19289468)

  • 21. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway.
    Marques-Fernandez F; Planells-Ferrer L; Gozzelino R; Galenkamp KM; Reix S; Llecha-Cano N; Lopez-Soriano J; Yuste VJ; Moubarak RS; Comella JX
    Cell Death Dis; 2013 Feb; 4(2):e493. PubMed ID: 23412386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.
    Turner A; Li LC; Pilli T; Qian L; Wiley EL; Setty S; Christov K; Ganesh L; Maker AV; Li P; Kanteti P; Das Gupta TK; Prabhakar BS
    PLoS One; 2013; 8(2):e56817. PubMed ID: 23457619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
    Murakami-Mori K; Mori S; Bonavida B; Nakamura S
    J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS; Mulherkar N; Prasad KV
    Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of Homer 1a on tumor necrosis factor-α with cycloheximide-induced apoptosis is mediated by mitogen-activated protein kinase pathways.
    Luo P; Zhao Y; Li D; Chen T; Li S; Chao X; Liu W; Zhang L; Qu Y; Jiang X; Lu G; Poon W; Fei Z
    Apoptosis; 2012 Sep; 17(9):975-88. PubMed ID: 22660975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Qiao G; Kunda N; Maker AV; Prabhakar BS
    Endocr Relat Cancer; 2019 Jun; 26(6):551-563. PubMed ID: 30999276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic analysis.
    Hassan M; Zahid S; Alashwal H; Kloczkowski A; Moustafa AA
    Sci Rep; 2021 Jun; 11(1):12256. PubMed ID: 34112868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
    Sharma V; Tewari R; Sk UH; Joseph C; Sen E
    Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.
    Wang R; Li JC
    Asian Pac J Cancer Prev; 2015; 16(7):2751-6. PubMed ID: 25854358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.
    Ji W; Li Y; Wan T; Wang J; Zhang H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2271-9. PubMed ID: 22743059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
    Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL
    Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.
    Bi W; Wei Y; Wu J; Sun G; Guo Y; Zhang Q; Dong L
    Oncol Rep; 2013 Apr; 29(4):1533-9. PubMed ID: 23443411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-alpha-mediated activation of NF-kappaB and caspase-8.
    Ogura H; Tsukumo Y; Sugimoto H; Igarashi M; Nagai K; Kataoka T
    Exp Cell Res; 2008 Apr; 314(6):1406-14. PubMed ID: 18289527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
    Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
    Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
    Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.